Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06541132
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-02
Brief Title:
Positive Association of US-FLI With the Severity of CAD
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Positive Association Between Ultrasonographic Fatty Liver Indicator and the Severity of Coronary Artery Disease
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
As a multisystem disease metabolic dysfunction-associated fatty liver disease MAFLD is closely linked to the onset and progression of coronary heart disease CHD Ultrasonographic fatty liver indicator US-FLI is a semi-quantitative tool for evaluating the degree of hepatic steatosis Our study aims to explore the relationship between US-FLI based on MAFLD and the severity of CHD
Detailed Description:
204 patients who had invasive coronary angiography performed between July 2022 and December 2023 at the cardiology department of the Second Affiliated Hospital of Chongqing Medical University were included in this study Collect clinical information and abdominal ultrasound images from each patient Hepatic steatosis which quantified by US-FLI was evaluated by the echo contrast between liver and kidney posterior attenuation of ultrasound beam areas of focal sparing display of hepatic vessels gallbladder wall and diaphragm Fatty liver was diagnosed when US-FLI2 The severity of CHD was evaluated using the SYNTAX score SS and a total of 100 CHD patients were ultimately diagnosed CHD patients were further divided into the low-risk group SS 22 54 cases and the medium-high-risk group SS23 46 cases Multivariate logistic regression model was used to assess the relationship between US-FLI and SS in patients with MAFLD The receiver operating characteristic curve was used to determine the accuracy sensitivity and specificity of US-FLI in predicting SS
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None